Cargando…

Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer

BACKGROUND: PREDICT (http://www.predict.nhs.uk) is a prognostication and treatment benefit tool for early breast cancer (EBC). The aim of this study was to incorporate the prognostic effect of KI67 status in a new version (v3), and compare performance with the Predict model that includes HER2 status...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wishart, Gordon C, Rakha, Emad, Green, Andrew, Ellis, Ian, Ali, Hamid Raza, Provenzano, Elena, Blows, Fiona M, Caldas, Carlos, Pharoah, Paul DP
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265394/ https://www.ncbi.nlm.nih.gov/pubmed/25472026 http://dx.doi.org/10.1186/1471-2407-14-908

Ejemplares similares

Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer
por: Ali, H R, et al.
Publicado: (2012)

Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
por: Ali, H Raza, et al.
Publicado: (2011)

Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer
por: Abubakar, Mustapha, et al.
Publicado: (2019)

Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections
por: Muftah, Abir A., et al.
Publicado: (2017)

Decline in Antigenicity of Tumor Markers by Storage Time Using Pathology Sections Cut From Tissue Microarrays
por: Blows, Fiona M., et al.
Publicado: (2016)

Ki67 assessment in invasive luminal breast cancer: a comparative study between different scoring methods
por: Lashen, Ayat, et al.
Publicado: (2022)

Cell Proliferation (KI-67) Expression Is Associated with Poorer Prognosis in Nigerian Compared to British Breast Cancer Women
por: Agboola, Ayodeji O. J., et al.
Publicado: (2013)

PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer
por: Wishart, Gordon C, et al.
Publicado: (2010)

Correction: PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer
por: Wishart, Gordon C, et al.
Publicado: (2010)

Proliferative Index (Ki67) for Prediction in Breast Duct Carcinomas
por: Ahmed, Shatha Th, et al.
Publicado: (2018)

Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67
por: Genç, C. G., et al.
Publicado: (2018)

An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation
por: Candido dos Reis, Francisco J., et al.
Publicado: (2017)

Clinical Significance of Ki-67 Labeling Index in Pituitary Macroadenoma
por: Paek, Kyung-Il, et al.
Publicado: (2005)

Significance of p53 and ki-67 expression in prostate cancer
por: Verma, Renuka, et al.
Publicado: (2015)

Impact of tissue sampling on accuracy of Ki67 immunohistochemistry evaluation in breast cancer
por: Besusparis, Justinas, et al.
Publicado: (2016)

Prognostic and predictive value of Ki-67 in triple-negative breast cancer
por: Wang, Wei, et al.
Publicado: (2016)

Radiomic prediction models for the level of Ki-67 and p53 in glioma
por: Sun, Xiaojun, et al.
Publicado: (2020)

The prognostic and predictive potential of Ki-67 in triple-negative breast cancer
por: Zhu, Xiuzhi, et al.
Publicado: (2020)

Virtual monoenergetic imaging predicting Ki-67 expression in lung cancer
por: Dou, Peipei, et al.
Publicado: (2023)

A nomogram incorporating Ki67 to predict survival of acral melanoma
por: Du, Yu, et al.
Publicado: (2023)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

The prognostic significance of p63 and Ki-67 expression in myoepithelial carcinoma
por: Jiang, You-Hua, et al.
Publicado: (2012)

Expression and Clinical Significance of Ki67 and SOX2 in Colorectal Cancer
por: Hu, Bo, et al.
Publicado: (2023)

Prognostic Value of Ki67 in Patients with Stage 1–2 Endometrial Cancer: Validation of the Cut-off Value of Ki67 as a Predictive Factor
por: Jiang, Peng, et al.
Publicado: (2020)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Ki67 Antigen as a Predictive Factor for Prognosis of Sinonasal Mucosal Melanoma
por: Kim, Dong-Kyu, et al.
Publicado: (2008)

Ki-67 Expression in CRC Lymph Node Metastasis Does Not Predict Survival
por: Martins, Sandra F., et al.
Publicado: (2015)

Ki-67 Expression as a Predictive Factor of Muscle Invasion in Bladder Cancer
por: Warli, Syah Mirsya, et al.
Publicado: (2018)

Pulmonary neuroendocrine carcinoid tumors: Is there a predictive role to the Ki 67 index?
por: Patané, Ana Karina, et al.
Publicado: (2021)

Can we use Ki67 expression to predict prostate cancer aggressiveness?
por: MAIA, RONALDO, et al.
Publicado: (2022)

Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival
por: Dawson, S J, et al.
Publicado: (2009)

What is the Prognostic Significance of Ki-67 Positivity in Oral Squamous Cell Carcinoma?
por: Xie, Shang, et al.
Publicado: (2016)

Expression and Significance of COX-2 and Ki-67 in Hepatolithiasis with Bile Duct Carcinoma
por: Wang, Ping, et al.
Publicado: (2015)

The clinicopathological significance of Ki67 in papillary thyroid carcinoma: a suitable indicator?
por: Tang, Jingdong, et al.
Publicado: (2018)

Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma
por: Song, Jinbo, et al.
Publicado: (2021)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma
por: Wangsa, D, et al.
Publicado: (2008)

Keratocystic Odontogenic Tumors: Predictive Factors of Recurrence by Ki-67 and AgNOR Labelling
por: Selvi, Firat, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_c54mgn6hjc4fprbucgka0d251r